Details for 2017853838
Up to date per 02.04.2026
Actions
Details for 2017853838
Granted/Registered
European Patent
31.07.2019 A
10.08.2022 B1
21.09.2016
US
201662397752 P
05.06.2017
US
201762515480 P
C07K 16/28 20060101AFI20200324BHEP
Owner
ALX Oncology Inc.323 Allerton Avenue South San Francisco, CA 94080US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
PONS, Jaumec/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100 Burlingame, CA 94010US
SIM, Bang Janetc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100 Burlingame, CA 94010US
WAN, Hongc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100 Burlingame, CA 94010US
KUO, Tracy Chia-Chienc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100 Burlingame, CA 94010US
KAUDER, Steven Elliotc/o ALX ONCOLOGY INC. 866 Malcolm Road Suite 100 Burlingame, CA 94010US
HARRIMAN, William Donc/o Crystal Bioscience Inc. 5980 Horton Street Suite 405 Emeryville, CA 94608-2059US
IZQUIERDO, Shelleyc/o Crystal Bioscience Inc. 5980 Horton Street Suite 405 Emeryville, CA 94608-2059US
Information about Fees